Glenmede Trust’s EMULEX CORP ELX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-557
Closed -$4K 2892
2015
Q1
$4K Hold
557
﹤0.01% 2310
2014
Q4
$3K Hold
557
﹤0.01% 2397
2014
Q3
$2K Sell
557
-1,459
-72% -$7.9K ﹤0.01% 2368
2014
Q2
$11K Sell
2,016
-17,592
-90% -$105K ﹤0.01% 2034
2014
Q1
$144K Buy
19,608
+5,250
+37% +$38.6K ﹤0.01% 1287
2013
Q4
$102K Sell
14,358
-49,335
-77% -$366K ﹤0.01% 1397
2013
Q3
$494K Buy
63,693
+8,110
+15% +$63K 0.01% 824
2013
Q2
$362K Buy
+55,583
New +$350K ﹤0.01% 874

Glenmede Trust's ELX Position: Q2 2015 in Review

Glenmede Trust sold out of EMULEX CORP (ELX) in Q2 2015, closing a stake of 557 shares — an estimated $4K sold.

Glenmede Trust first reported a position in ELX in Q2 2013 and held it in 8 quarters. The position peaked at $494K in Q3 2013. 0 funds tracked by Wall St. Rank hold ELX as of Q2 2015.

  • Glenmede Trust reported no remaining EMULEX CORP position as of Q2 2015 after selling out during the quarter.
  • Glenmede Trust sold 557 EMULEX CORP shares in Q2 2015, an estimated $4K.
  • Glenmede Trust first reported a position in EMULEX CORP in Q2 2013 and held it in 8 quarters.
  • Glenmede Trust's EMULEX CORP position peaked at $494K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held EMULEX CORP as of Q2 2015.

Based on Glenmede Trust's 13F filing for Q2 2015, filed 22 Jul 2015.